THE ALUNBRIG® (brigatinib) SMART™ FREE TRIAL PROGRAM
The ALUNBRIG SMART Free Trial Program can help you and your patients with ALK+ metastatic NSCLC assess whether ALUNBRIG is right for them by offering a 1-month free trial.
To get your eligiblea patient started:
There is no obligation to continue the use of ALUNBRIG after the free trial has been completed. If you decide ALUNBRIG is right for your patient, a prescription will need to be written.
aReview patient eligibility criteria—certain restrictions apply.
Want more info on Access with ALUNBRIG?
Takeda Oncology Here2Assist® Program
Explore help for your coverage, financial, and educational needs.